Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

TIL

Instill Bio (TIL)

Instill Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TIL
DateTimeSourceHeadlineSymbolCompany
24/12/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
22/11/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TILInstill Bio Inc
14/11/202409:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TILInstill Bio Inc
13/11/202423:39Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
13/11/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
13/11/202423:00GlobeNewswire Inc.Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
26/10/202412:42Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TILInstill Bio Inc
26/10/202412:42Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TILInstill Bio Inc
24/09/202403:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
16/09/202420:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/09/202420:00GlobeNewswire Inc.Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast CancerNASDAQ:TILInstill Bio Inc
09/09/202420:05IH Market NewsDell, Palantir, and Erie Will Be Added to the S&P 500; Boeing Avoids Strike; Apple Event Takes Place TodayNASDAQ:TILInstill Bio Inc
07/09/202407:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
16/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/08/202407:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
14/08/202407:00GlobeNewswire Inc.Instil Bio Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
14/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
02/08/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
01/08/202420:00GlobeNewswire Inc.Instil Bio and ImmuneOnco Announce License and Collaboration Agreement for Development of IMM2510, a Potentially Best-in-Class PD-L1xVEGF Bispecific Antibody, and IMM27M, a Novel Next-Generation Anti-CTLA-4 AntibodyNASDAQ:TILInstill Bio Inc
12/07/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
18/06/202407:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/06/202407:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
14/06/202407:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
10/05/202421:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TILInstill Bio Inc
10/05/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
10/05/202421:00GlobeNewswire Inc.Instil Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
22/03/202408:00GlobeNewswire Inc.Instil Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:TILInstill Bio Inc
15/02/202408:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
14/02/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TILInstill Bio Inc
18/01/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TILInstill Bio Inc
 Showing the most relevant articles for your search:NASDAQ:TIL